RDHL Stock Eyes Best Day in Years After Bull Note

RDHL is poised for its strongest one-day gain in four years

by Karee Venema

Published on Jul 12, 2019 at 1:44 PM

Redhill Biopharma Ltd (NASDAQ:RDHL) stock is near the top of the Nasdaq today, up 12.7% at $7.48, after the Israel-based drugmaker saw some bullish brokerage attention. Specifically, WBB Securities raised its rating to "strong buy" from "buy," and reiterated its $17 price target -- a 156% premium to last night's close.

The firm said it expects the Food and Drug Administration (FDA) to approve TALICIA, Redhill Biopharma's treatment for Helicobacter pylori (H. pylori) bacterial infection. The regulatory agency accepted the company's new drug application on July 3, and WBB Securities thinks the drug will "enter a lucrative market, estimated at $1.4 billion in the U.S. and $4.8 billion globally."

RDHL stock is now headed toward its best day since June 2015 -- breaking out above recent resistance at its 20-day moving average, and bringing its year-to-date gain to 35%. However, the shares ran smack into their 80-day moving average earlier, a trendline that hasn't been toppled on a year-to-date basis since late April.

Analysts overwhelmingly share WBB Securities' bullish assessment of RDHL, with all 100% of those in coverage maintaining a "buy" or "strong buy" rating on the stock. Plus, the average 12-month price target sits all the way up at $21.17.

rdhl stock daily price chart on july 12


A Schaeffer's exclusive!

The Expert's Guide

Access your FREE trading earning announcements before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


With This Lithium Stock, It Will Be Better to Be Too Early Than Too Late
Click to continue to advertiser's site.
HPQ Struggles After Revenue, Forecast Miss
HP posted an earnings beat, but revenue that fell short of estimates
New Highs for Dollar General Stock After Earnings
Dollar General's first quarter earnings and revenue topped Wall Street's estimates
With This Lithium Stock, It Will Be Better to Be Too Early Than Too Late
Click to continue to advertiser's site.